Anhui Anke Biotechnology (Group) Company., Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Anke Biotechnology (Group) Company., Limited with three other
companies in this sector in CHINA :
Jinyu Bio-Technology Co Ltd
sales of 1.58 billion Chinese Renmimbi [US$246.10 million]
of which 96%
Vcanbio Cell & Gene Engineering Corp Ltd
(1.32 billion Chinese Renmimbi [US$204.88 million]
of which 61%
was Manufacturing), and
Tianjin Ringpu Bio-Technology Co Ltd
(2.00 billion Chinese Renmimbi [US$311.20 million]
of which 56%
was Veterinary Biological Products).
During the second
quarter of 2021, sales at Anhui Anke Biotechnology (Group) Company., Limited totalled
479.84 million Chinese Renmimbi.
an increase of 20.5%
from the 398.28 million Chinese Renmimbi in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 969.24 million Chinese Renmimbi, which is
than through the first two quarters of 2020.
Sales at Anhui Anke Biotechnology (Group) Company., Limited appear to have some seasonality: during each of the previous 9
years, sales have been highest during the fourth quarter, which has accounted for
between 27.9% and 32.8%
of the annual
During the year ended December of 2020, sales at
Anhui Anke Biotechnology (Group) Company., Limited were 1.70 billion Chinese Renmimbi (US$264.69 million).
decrease of 0.6%
versus 2019, when the company's sales were 1.71 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 23.7% decline
in Raw Material Medicine, from 77.68 million Chinese Renmimbi to 59.26 million Chinese Renmimbi.
There were also decreases in sales in
Medicine (down 6.9% to 456.27 million Chinese Renmimbi)
Chemical Synthetic Drugs (down 0.5% to 126.25 million Chinese Renmimbi)
Technical Services (down 10.6% to 117.80 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Biological Products (up 4.0% to 895.38 million Chinese Renmimbi)
Others (up 87.3% to 46.46 million Chinese Renmimbi)